Clinical Trial Update: Evaluate the Implementation of Using Indocyanine Green for Sentinel Lymph Node Mapping in Breast Cancer Patients [NA]

View source ↗

Summary

A clinical trial update indicating recruitment to evaluate using indocyanine green for sentinel lymph node mapping in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Casa di Cura Dott. Pederzoli | Conditions: Breast Cancer | NA | Status: RECRUITING